Researchers Tease Out Glitches in Immune System's Self-Recognition
News Nov 22, 2014
Immunity is a thankless job. Though the army of cells known as the immune system continuously keeps us safe from a barrage of viruses, bacteria and even precancerous cells, we mainly notice it when something goes wrong: “Why did I get the flu this year even though I got vaccinated?” “Why does innocent pollen turn me into a red-eyed, sniffling mess?”
A new study from Johns Hopkins takes a big step toward answering this and other questions about immunity, shedding light on how the body recognizes enemies on the molecular level - and how that process can go wrong. The results appear Nov. 21, in the online journal Nature Communications.
In the laboratory of Scheherazade Sadegh-Nasseri, Ph.D., a professor of immunology and pathology at the Johns Hopkins University School of Medicine, research centers on how the immune system “selects” bits of protein to become so-called dominant epitopes. It’s these red flags that white blood cells will be programmed to fight. Sadegh-Nasseri’s research team spent years devising a mixture of proteins and chemicals that replicates the complex cellular processing that yields the dominant epitopes.
“We wanted to know how one particular epitope becomes the dominant one that white blood cells look for when they’re battling a given foe,” Sadegh-Nasseri says.
Postdoctoral fellow AeRyon Kim, Ph.D., explains that the epitope-generating system enabled her and others on Sadegh-Nasseri’s team to discriminate differences in the selection processes for proteins from pathogenic microbes versus human proteins: “We found that epitopes from human proteins that are associated with autoimmune diseases, like diabetes and rheumatoid arthritis, are generated through a different process than are proteins from pathogens.”
The pathogen-derived epitopes bind to protein receptors that protect them from the specialized processing enzymes that chop them up, the research group found. However, autoimmune-causing epitopes are resistant to destruction by those enzymes even without protection by their receptor proteins.
Ultimately, Kim says, “When a critical mass of one epitope accumulates, it becomes dominant.” The dominant epitope is then “presented” to newly minted T cells, which trains them to either destroy the foe or attack the body’s own cells, ultimately causing inflammation.
“Knowing how these dominant epitopes arise - and having a system that lets us predict which will be dominant - is a big step toward understanding the roots of autoimmune diseases,” says Sadegh-Nasseri. “It could also help in training the immune system - for example, in vaccine development.”
Latent HIV Reservoirs Inherently Resistant to Elimination by CD8+ T-cellsNews
The latest “kick-and-kill” research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study found that latent HIV reservoirs show resistance to CD8+ T-cells, a type of white blood cell whose primary function is to kill infected cells.READ MORE
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE
Changes in Mother's Bacteria Linked to Preterm BirthsNews
Changes to the communities of microbes living in the reproductive tract of pregnant women could help to spot those at risk of giving birth prematurely. A study of hundreds of women found that subtle changes to the bacteria present in the vagina were strongly associated with the mother’s waters breaking early and preterm birth – the baby being born before 37 weeks.READ MORE